CIK: 0001858703
Total reported value
$372.2M
Reporting period: 2026-03-31 · Number of holdings: 76
Blue Owl Capital Holdings LP disclosed 76 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $372.2M and a quarterly turnover rate of 60.7%.
Browse other institutions with $100M to $1B AUMBrowse other institutions starting with "B"
Blue Owl Capital Holdings LP's disclosed holdings carry a Herfindahl concentration index of 0.063 — mathematically equivalent to about 16 equally-sized positions, well below its 76 actual disclosed holdings. That gap points to a strategy built around a small core of high-conviction bets rather than broad diversification.
Position sizes vary widely across the portfolio (a coefficient of variation of 1.94), with a handful of outsized bets alongside many smaller positions.
No strong tilt toward either adding to existing winners or initiating outsized new positions was observed in the latest reported quarter.
Sector classification currently covers about 8% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Add MPLT
+207.6% $14.7M
Trim OBDC
0.0% -$3.5M
Trim SGMT
-73.2% -$5.6M
Trim HLLY
+2.2% -$4.1M
Trim CMPX
-15.1% -$3.1M
Trim NCDL
0.0% -$1.3M
Showing top 75 holdings (of 76 total)
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | AKTS | Aktis Oncology INC | Stock-Other | 15.20% | +15.20% | NEW | |
| 2 | LRMR | Larimar Therapeutics INC | Stock-Other | 8.61% | +0.59% | +4.34% | |
| 3 | ✓ | Engene Holdings INC | Stock-Other | 8.08% | -1.29% | +31.40% | |
| 4 | NCDL | Nuveen Churchill Direct Lend | Stock-Other | 7.33% | -1.49% | — | |
| 5 | CGEM | Cullinan Therapeutics INC | Stock-Other | 7.29% | -0.22% | -18.77% | |
| 6 | OBDC | Blue Owl Capital CORP | Stock-Financials | 6.08% | -1.98% | — | |
| 7 | MPLT | Maplight Therapeutics INC | Stock-Other | 5.49% | +3.72% | +207.57% | |
| 8 | CMPX | Compass Therapeutics INC | Stock-Other | 4.18% | -1.56% | -15.14% | |
| 9 | CNTX | Context Therapeutics INC | Stock-Other | 3.58% | +0.21% | -31.53% | |
| 10 | HLLY | Holley INC | Stock-Other | 3.49% | -1.80% | +2.18% | |
| 11 | EYPT | Eyepoint INC | Stock-Other | 3.16% | +0.95% | +132.45% | |
| 12 | CRVS | Corvus Pharmaceuticals INC | Stock-Other | 2.14% | +2.14% | NEW | |
| 13 | CNDT | Conduent INC | Stock-Other | 1.73% | -1.13% | +4.44% | |
| 14 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 1.70% | +0.19% | +42.33% | |
| 15 | AQST | Aquestive Therapeutics INC | Stock-Other | 1.50% | +0.45% | +156.75% | |
| 16 | RYTM | Rhythm Pharmaceuticals INC | Stock-Other | 1.44% | +1.44% | NEW | |
| 17 | ✓ | Compass Pathways PLC | Stock-Other | 1.38% | +1.38% | NEW | |
| 18 | IMMX | Immix Biopharma INC | Stock-Other | 1.34% | — | -44.48% | |
| 19 | IMA | Imagenebio INC | Stock-Other | 1.29% | -0.46% | +16.45% | |
| 20 | CVEO | Civeo CORP | Stock-Other | 1.28% | -1.34% | -51.29% | |
| 21 | LENZ | Lenz Therapeutics INC | Stock-Other | 1.25% | +0.51% | +237.81% | |
| 22 | ELDN | Eledon Pharmaceuticals INC | Stock-Other | 1.18% | +0.28% | -26.43% | |
| 23 | 4XC1 | Kalvista Pharmaceuticals INC | Stock-Other | 1.16% | -0.63% | -40.28% | |
| 24 | OVID | Ovid Therapeutics INC | Stock-Other | 1.14% | +1.14% | NEW | |
| 25 | PVLA | Palvella Therapeutics INC | Stock-Other | 1.05% | -0.25% | -22.36% | |
| 26 | PLRX | Pliant Therapeutics INC | Stock-Other | 1.01% | — | — | |
| 27 | STWD | Starwood Property Trust INC | Stock-Real Estate | 0.73% | +0.73% | NEW | |
| 28 | ✓ | Adc Therapeutics SA | Stock-Other | 0.70% | -0.21% | — | |
| 29 | EVMN | Evommune INC | Stock-Other | 0.62% | +0.62% | NEW | |
| 30 | DELL | Dell Technologies -c | Stock-Tech | 0.61% | -1.48% | -74.19% | |
| 31 | ✓ | Larimar Therapeutics INC | Stock-Other | 0.51% | +0.51% | NEW | |
| 32 | ORIC | Oric Pharmaceuticals INC | Stock-Other | 0.51% | -0.79% | -70.87% | |
| 33 | SGMT | Sagimet Biosciences Inc-a | Stock-Other | 0.47% | -1.80% | -73.16% | |
| 34 | WW | Ww International Inc-new | Stock-Other | 0.35% | +0.35% | NEW | |
| 35 | ✓ | Engene Holdings INC | Stock-Other | 0.35% | +0.32% | +1316.00% | |
| 36 | EPD | Enterprise Products Partners | Stock-Energy | 0.32% | — | — | |
| 37 | FLD | Fold Holdings INC | Stock-Other | 0.30% | — | — | |
| 38 | OPTXW | Omnilit Acquisition Cl A -23 | Stock-Other | 0.23% | +0.17% | — | |
| 39 | MRKR | Marker Therapeutics INC | Stock-Other | 0.19% | — | — | |
| 40 | ✓ | Mineralys Therapeutics INC | Stock-Other | 0.16% | +0.16% | NEW | |
| 41 | NIOBW | Niocorp Developments LTD -28 | Stock-Other | 0.14% | -0.37% | -63.47% | |
| 42 | ✓ | Compass Therapeutics INC | Stock-Other | 0.13% | +0.13% | NEW | |
| 43 | BNAIW | Brand Engagement Netwo -cw27 | Stock-Other | 0.11% | +0.08% | -38.86% | |
| 44 | CAH | Cardinal Health INC | Stock-Healthcare | 0.10% | — | — | |
| 45 | ✓ | Rezolve Ai LTD | Stock-Other | 0.05% | — | -18.73% | |
| 46 | PIPR | Piper Sandler Cos | Stock-Financials | 0.05% | — | — | |
| 47 | ✓ | Alpha Modus Hldgs INC | Stock-Other | 0.04% | — | — | |
| 48 | ET | Energy Transfer LP | Stock-Energy | 0.03% | — | — | |
| 49 | ✓ | Stock-Other | 0.03% | — | — | ||
| 50 | CAI | Caris Life Sciences INC | Stock-Other | 0.02% | — | — |
Performance for Q3 2026
+7.6%
Performance Last 4 Quarters
+35.8%
Based on 71% of reported portfolio value with available pricing
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2026-03-31 | 76 | $372.2M | 61 | |
| 2025-12-31 | 82 | $324.0M | 52 | |
| 2025-09-30 | 75 | $322.1M | 59 | |
| 2025-06-30 | 73 | $309.9M | 0 | |
| 2025-03-31 | 74 | $310.1M | 0 | |
| 2024-12-31 | 80 | $434.0M | 0 | |
| 2024-09-30 | 141 | $518.4M | 0 | |
| 2024-06-30 | 43 | $359.6M | 0 | |
| 2024-03-31 | 49 | $500.6M | 0 | |
| 2023-12-31 | 46 | $418.3M | 0 | |
| 2023-09-30 | 19 | $129.3M | 0 | |
| 2023-06-30 | 22 | $162.3M | 0 | |
| 2023-03-31 | 19 | $156.1M | 0 | |
| 2022-12-31 | 56 | $235.0M | 0 | |
| 2022-09-30 | 52 | $230.9M | 0 | |
| 2022-06-30 | 49 | $203.6M | 0 | |
| 2022-03-31 | 41 | $227.2M | 0 | |
| 2021-12-31 | 30 | $1.9B | 0 |
Blue Owl Capital Holdings LP's most significant position changes for 2026-03-31: New buy: Aktis Oncology INC (AKTS); Sold out: Repare Therapeutics INC (RPTX); New buy: Corvus Pharmaceuticals INC (CRVS); Sold out: Procore Technologies INC (PCOR); Sold out: Roivant Sciences Ltd. (ROIV).
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | MPLT | Maplight Therapeutics INC | +3.7% | +207.57% | Add |
| 2 | EYPT | Eyepoint INC | +1% | +132.45% | Add |
| 3 | LRMR | Larimar Therapeutics INC | +0.6% | +4.34% | Add |
| 4 | LENZ | Lenz Therapeutics INC | +0.5% | +237.81% | Add |
| 5 | AQST | Aquestive Therapeutics INC | +0.5% | +156.75% | Add |
| 6 | ✓ | Engene Holdings INC | +0.3% | +1316.00% | Add |
| 7 | ELDN | Eledon Pharmaceuticals INC | +0.3% | -26.43% | Trim |
| 8 | CNTX | Context Therapeutics INC | +0.2% | -31.53% | Trim |
| 9 | RARE | Ultragenyx Pharmaceutical In | +0.2% | +42.33% | Add |
| 10 | OPTXW | Omnilit Acquisition Cl A -23 | +0.2% | — | Unchanged |
| 11 | BNAIW | Brand Engagement Netwo -cw27 | +0.1% | -38.86% | Trim |
| 12 | ✓ | Adc Therapeutics SA | -0.2% | — | Unchanged |
| 13 | CGEM | Cullinan Therapeutics INC | -0.2% | -18.77% | Trim |
| 14 | PVLA | Palvella Therapeutics INC | -0.3% | -22.36% | Trim |
| 15 | NIOBW | Niocorp Developments LTD -28 | -0.4% | -63.47% | Trim |
| 16 | IMA | Imagenebio INC | -0.5% | +16.45% | Add |
| 17 | 4XC1 | Kalvista Pharmaceuticals INC | -0.6% | -40.28% | Trim |
| 18 | ORIC | Oric Pharmaceuticals INC | -0.8% | -70.87% | Trim |
| 19 | CNDT | Conduent INC | -1.1% | +4.44% | Add |
| 20 | ✓ | Engene Holdings INC | -1.3% | +31.40% | Add |
| 21 | CVEO | Civeo CORP | -1.3% | -51.29% | Trim |
| 22 | DELL | Dell Technologies -c | -1.5% | -74.19% | Trim |
| 23 | NCDL | Nuveen Churchill Direct Lend | -1.5% | — | Unchanged |
| 24 | CMPX | Compass Therapeutics INC | -1.6% | -15.14% | Trim |
| 25 | SGMT | Sagimet Biosciences Inc-a | -1.8% | -73.16% | Trim |
| 26 | HLLY | Holley INC | -1.8% | +2.18% | Add |
| 27 | OBDC | Blue Owl Capital CORP | -2% | — | Unchanged |
| 28 | AKTS | Aktis Oncology INC | — | NEW | New buy |
| 29 | RPTX | Repare Therapeutics INC | — | EXIT | Sold out |
| 30 | CRVS | Corvus Pharmaceuticals INC | — | NEW | New buy |
| 31 | PCOR | Procore Technologies INC | — | EXIT | Sold out |
| 32 | ROIV | Roivant Sciences Ltd. | — | EXIT | Sold out |
| 33 | RYTM | Rhythm Pharmaceuticals INC | — | NEW | New buy |
| 34 | ✓ | Compass Pathways PLC | — | NEW | New buy |
| 35 | IMRX | Immuneering CORP - Class A | — | EXIT | Sold out |
| 36 | OVID | Ovid Therapeutics INC | — | NEW | New buy |
| 37 | PAYO | Payoneer Global INC | — | EXIT | Sold out |
| 38 | 260 | Centessa Pharmaceuticals-adr | — | EXIT | Sold out |
| 39 | CMPS | Compass Pathways PLC | — | EXIT | Sold out |
| 40 | NU | Nu Holdings Ltd. | — | EXIT | Sold out |
| 41 | STWD | Starwood Property Trust INC | — | NEW | New buy |
| 42 | MLYS | Mineralys Therapeutics INC | — | EXIT | Sold out |
| 43 | EVMN | Evommune INC | — | NEW | New buy |
| 44 | ✓ | Larimar Therapeutics INC | — | NEW | New buy |
| 45 | JANX | Janux Therapeutics INC | — | EXIT | Sold out |
| 46 | WW | Ww International Inc-new | — | NEW | New buy |
| 47 | CHYM | Chime Financial Inc-cl A | — | EXIT | Sold out |
| 48 | ✓ | Mineralys Therapeutics INC | — | NEW | New buy |
| 49 | ✓ | Compass Therapeutics INC | — | NEW | New buy |
| 50 | ✓ | Alpha Tau Medical LTD | — | EXIT | Sold out |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2026-03-31 | 2026-05-14 | 13F-HR | View on EDGAR |
| 2025-12-31 | 2026-02-20 | Amendment | View on EDGAR |
| 2025-12-31 | 2026-02-09 | 13F-HR | View on EDGAR |
| 2025-09-30 | 2025-11-12 | 13F-HR | View on EDGAR |
| 2025-06-30 | 2025-08-11 | 13F-HR | View on EDGAR |
| 2025-03-31 | 2025-05-15 | 13F-HR | View on EDGAR |
| 2024-12-31 | 2025-02-14 | 13F-HR | View on EDGAR |
| 2024-09-30 | 2024-11-14 | 13F-HR | View on EDGAR |
| 2024-06-30 | 2024-08-15 | 13F-HR | View on EDGAR |
| 2024-03-31 | 2024-05-15 | 13F-HR | View on EDGAR |
| 2023-12-31 | 2024-02-15 | 13F-HR | View on EDGAR |
| 2023-09-30 | 2023-11-14 | 13F-HR | View on EDGAR |
| 2023-06-30 | 2023-08-11 | 13F-HR | View on EDGAR |
| 2023-03-31 | 2023-05-11 | 13F-HR | View on EDGAR |
| 2022-12-31 | 2023-02-13 | 13F-HR | View on EDGAR |
| 2022-09-30 | 2022-11-14 | 13F-HR | View on EDGAR |
| 2022-06-30 | 2022-08-12 | 13F-HR | View on EDGAR |
| 2022-03-31 | 2022-05-16 | 13F-HR | View on EDGAR |
| 2021-12-31 | 2022-05-16 | Amendment | View on EDGAR |
| 2021-12-31 | 2022-05-16 | Amendment | View on EDGAR |
| 2021-12-31 | 2022-02-11 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001908619
Total reported value
$372.1M
46 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001963404
Total reported value
$372.3M
14 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001844375
Total reported value
$372.3M
100 stks
2026-06-30
AUM within 0.0% of this institution
Institutions with overlapping top holdings
CIK 0001687078
Total reported value
$1.3B
41 stks
2026-03-31
2 of the top 5 holdings overlap, including Cullinan Therapeutics INC
CIK 0001791468
Total reported value
$252.3M
28 stks
2023-09-30
Stale — no recent filing
1 of the top 5 holdings overlap, including Cullinan Therapeutics INC
CIK 0001910456
Total reported value
$632.7M
23 stks
2026-03-31
1 of the top 5 holdings overlap, including Cullinan Therapeutics INC